Similarly, in TRAMP-C1 prostate tumors, CCR5 ligands induced the expansion of MDSCs in the bone marrow, and CCR5 drove the migration of MDSCs from the bone marrow into the blood and finally their recruitment at the tumor site (Hawila et al., 2017). The gene discussed is CCR5; the disease is neoplasm.